HROW vs TXT · rev $114.9M vs P/E 19, rev $7.52B
Harrow Health Inc (HROW) versus Textron Inc (TXT) — a side-by-side from cached financials, not a winner call.
Harrow Health Inc (HROW) is a drug manufacturers - specialty & generic company listed on US.
Textron Inc (TXT) is a aerospace & defense company listed on US.
Latest reported HROW revenue for 2026-06-30 was $114.9M. Net income was -$44.9M. HROW currently screens at market cap $1.28B.
Latest reported TXT revenue for 2026-07-04 was $7.52B. Net income was $468.0M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
HROW currently screens at market cap $1.28B. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
Not investment advice. Open the HROW and TXT stock pages for the full models.
Not investment advice.